| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Oxytetracycline hydrochloride |
Is a |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Oxytetracycline measurement |
Component |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Accidental oxytetracycline poisoning |
Causative agent (attribute) |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Intentional oxytetracycline poisoning |
Causative agent (attribute) |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| intoxication par l'oxytétracycline d'intention indéterminée |
Causative agent (attribute) |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Oxytetracycline adverse reaction |
Causative agent (attribute) |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Allergy to oxytetracycline |
Causative agent (attribute) |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Oxytetracycline overdose (disorder) |
Causative agent (attribute) |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Accidental oxytetracycline overdose |
Causative agent (attribute) |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Intentional oxytetracycline overdose |
Causative agent (attribute) |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| surdose d'oxytétracycline d'intention indéterminée |
Causative agent (attribute) |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Oxytetracycline+lidocaine 50mg/mL/2% injection 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Oxytetracycline+lidocaine 50mg/mL/2% injection 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Oxytetracycline+lidocaine 125mg/mL/2% injection 2mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Oxytetracycline 200mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Oxytetracycline dihydrate (substance) |
Is a |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Poisoning by oxytetracycline |
Causative agent (attribute) |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing lidocaine and oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing clobetasone butyrate and nystatin and oxytetracycline |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Clobetasone butyrate+oxytetracycline+nystatin cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Accidental oxytetracycline poisoning |
Causative agent (attribute) |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Intentional oxytetracycline poisoning |
Causative agent (attribute) |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Product containing hydrocortisone and oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing oxytetracycline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing oxytetracycline in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Product containing oxytetracycline in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Product containing oxytetracycline in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Oxytetracycline calcium |
Is a |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Allergy to oxytetracycline |
Causative agent (attribute) |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely oxytetracycline (as oxytetracycline dihydrate) 250 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Oxytetracycline calcium |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Oxytetracycline dihydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Oxytetracycline hydrochloride |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
| Hydrocortisone- and oxytetracycline-containing product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Hydrocortisone 10 mg/g and oxytetracycline (as oxytetracycline hydrochloride) 30 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing clobetasone and nystatin and oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Oxytetracycline-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing oxytetracycline in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Oxytetracycline- and phenazopyridine- and sulfamethizole-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
2 |
| Oxytetracycline- and phenazopyridine- and sulfamethizole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
2 |
| Product containing only clobetasone and nystatin and oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydrocortisone and oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Oxytetracycline only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Oxytetracycline and phenazopyridine and sulfamethizole only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
2 |
| Product containing only lidocaine and oxytetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing only oxytetracycline and phenazopyridine and sulfamethizole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
2 |
| Oxytetracycline only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Oxytetracycline only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing only oxytetracycline in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing only oxytetracycline in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing only hydrocortisone and oxytetracycline in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely oxytetracycline 250 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely oxytetracycline 250 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
1 |
| Oxytetracycline anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Oxytetracycline (substance) |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]